1887
Letter Open Access
Like 0
Preview this article:

There is no abstract available.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2024.29.49.2400766
2024-12-05
2024-12-12
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2024.29.49.2400766
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/29/49/eurosurv-29-49-5.html?itemId=/content/10.2807/1560-7917.ES.2024.29.49.2400766&mimeType=html&fmt=ahah

References

  1. Del Riccio M, Nunes MC, Cowling BJ, Lina B, McCauley JW, Meijer A, et al. Post-disappearance scenarios: policy implications following the potential disappearance of B/Yamagata lineage influenza viruses. Euro Surveill. 2024;29(45):2400196.  https://doi.org/10.2807/1560-7917.ES.2024.29.45.2400196  PMID: 39512167 
  2. Koul PA. Influenza vaccination: A case for removal of B/Yamagata from the quadrivalent vaccine. Lung India. 2024;41(2):149-50.  https://doi.org/10.4103/lungindia.lungindia_66_24  PMID: 38380674 
  3. Monto AS, Zambon M, Weir JP. The end of B/Yamagata influenza transmission - transitioning from quadrivalent vaccines. N Engl J Med. 2024;390(14):1256-8.  https://doi.org/10.1056/NEJMp2314801  PMID: 38416423 
  4. World Health Organization (WHO). Recommended composition of influenza virus vaccines for use in the 2024-2025 northern hemisphere influenza season. Geneva: WHO; 2024.Available from: https://www.who.int/publications/m/item/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2024-2025-northern-hemisphere-influenza-season
  5. Di Pietra G, Di Sopra S, Conciatori V, Lavezzo E, Franchin E, Petris MG, et al. Vaccine-related influenza virus B infection in a child with an undiagnosed B-cell acute lymphoblastic leukemia. Int J Infect Dis. 2024;147:107184.  https://doi.org/10.1016/j.ijid.2024.107184  PMID: 39033799 
  6. Grohskopf LA, Ferdinands JM, Blanton LH, Broder KR, Loehr J. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices - United States, 2024-25 influenza season. MMWR Recomm Rep. 2024;73(5):1-25.  https://doi.org/10.15585/mmwr.rr7305a1  PMID: 39197095 
  7. European Medicines Agency (EMA). EU recommendations for 2024/2025 seasonal flu vaccine composition. Amsterdam: EMA; 2024. Available from: https://www.ema.europa.eu/en/news/eu-recommendations-2024-2025-seasonal-flu-vaccine-composition#:~:text=Manufacturers%20of%20live%2Dattenuated%20vaccines,Victoria%20lineage)%2Dlike%20virus
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error